Low Dose Dexmedetomidine as a Postoperative Pain Adjunct
Status:
Not yet recruiting
Trial end date:
2026-05-01
Target enrollment:
Participant gender:
Summary
This randomized controlled trial examines whether the addition of a low-dose dexmedetomidine
infusion to our current multimodal pain management plan decreases narcotic consumption and
reduces side effects in adolescent patients undergoing posterior spinal fusion for idiopathic
scoliosis.